MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.
Market capitalization (3-May-2021)
Closing stock price (3-May-2021)
MorphoSys has 1.45k Twitter Followers. The number of followers has increased 0.3% month over month and increased 3.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was MorphoSys founded?
MorphoSys was founded in 1992.
Who are MorphoSys key executives?
MorphoSys's key executives are Jean-Paul Kress, Malte Peters and Charlotte Lohmann.
How many employees does MorphoSys have?
MorphoSys has 615 employees.
Who are MorphoSys competitors?
Competitors of MorphoSys include Microcoat Biotechnologie, Prometheus Biosciences and Biosan Laboratories.
Where is MorphoSys headquarters?
MorphoSys headquarters is located at Semmelweisstraße 7, Planegg.
Where are MorphoSys offices?
MorphoSys has offices in Planegg and Boston.
How many offices does MorphoSys have?
MorphoSys has 2 offices.
Receive alerts for 300+ data fields across thousands of companies